MOORE THOMAS A

CIK 00012006993 companiesNORTH BRUNSWICK, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001200699

Recent Transactions

35 trades

Award
Ayala Pharmaceuticals, Inc.
Common Stock
2014-07-17+10,976→ 176,462 total
Exercise/Conversion
Ayala Pharmaceuticals, Inc.
Common Stock Warrants
2013-10-22$0.00/sh+20,332→ 20,332 total
Exercise/Conversion
Ayala Pharmaceuticals, Inc.
Common Stock
2013-10-22$4.00/sh+40,783→ 165,486 total
Conversion
Ayala Pharmaceuticals, Inc.
Convertible Promissory Note
2013-05-21→ 0 total
Conversion
Ayala Pharmaceuticals, Inc.
Common Stock
2013-05-21$0.03/sh+4,745,521→ 15,587,888 total
Award
Ayala Pharmaceuticals, Inc.
Option
2013-03-14+4,000,000→ 4,000,000 total
Disposition to Issuer
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2012-07-05−7,674,512→ 0 total
Award
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2012-07-05+7,674,512→ 7,674,512 total
Disposition to Issuer
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2012-07-05−400,000→ 0 total
Award
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2012-07-05+191,334→ 191,334 total
Award
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2012-07-05+2,798,765→ 2,798,765 total
Disposition to Issuer
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2012-07-05−191,334→ 0 total
Disposition to Issuer
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2012-07-05−2,798,765→ 0 total
Award
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2012-07-05+400,000→ 400,000 total
Award
Ayala Pharmaceuticals, Inc.
Convertible Promissory Note
2012-05-18
Award
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2012-05-18+400,000→ 400,000 total
Award
Ayala Pharmaceuticals, Inc.
Common Stock
2012-05-14+5,490,196→ 10,842,367 total
Disposition to Issuer
Ayala Pharmaceuticals, Inc.
Convertible Promissory Note
2012-05-14
Disposition to Issuer
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2012-05-14−1,568,627→ 0 total
Award
Ayala Pharmaceuticals, Inc.
Options
2011-11-08+4,000,000→ 4,000,000 total
Award
Ayala Pharmaceuticals, Inc.
Options
2011-11-08+4,200,000→ 4,200,000 total
Award
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2011-10-31+1,568,627→ 1,568,627 total
Award
Ayala Pharmaceuticals, Inc.
Convertible Promissory Note
2011-10-31
Disposition to Issuer
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2011-08-29+2,666,667→ 0 total
Award
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2011-08-29+7,674,512→ 7,674,512 total
Purchase
Ayala Pharmaceuticals, Inc.
Common Stock Warrants (right to buy)
2011-06-24$0.03/sh+3,698,765→ 3,698,765 total
Award
Ayala Pharmaceuticals, Inc.
Options
2010-10-14+2,000,000→ 2,000,000 total
Award
Ayala Pharmaceuticals, Inc.
Common Stock
2010-06-29+750,000→ 5,352,171 total
Other
Ayala Pharmaceuticals, Inc.
Common Stock
2010-04-29$0.17/sh+1,176,471→ 8,585,505 total
Award
Ayala Pharmaceuticals, Inc.
Options
2009-07-21+2,500,000→ 4,900,000 total
Award
Ayala Pharmaceuticals, Inc.
Common Stock
2008-04-04+750,000→ 3,425,700 total
Other
Ayala Pharmaceuticals, Inc.
Common Stock
2008-02-01+9,033→ 2,675,700 total
Award
Synvista Therapeutics, Inc.
Stock Option
2005-06-29+20,000→ 75,000 total
Sale
BIOPURE CORP
Class A Common Stock
2003-08-07$2.42/sh−8,750→ 322,862 total
Sale
BIOPURE CORP
Warrant-Common Stock
2003-08-05−3,500→ 37,822 total

Companies

Recent Filings

Address

C/O ADVAXIS, INC. TECHNOLOGY CTR OF NJ, 675 US HIGHWAY ONE

NORTH BRUNSWICK, NJ, 08902

View on SEC.gov